The Investigative Medicine Division aims to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Specific research groups include:
The Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), which aims to deliver cutting edge research that will improve the assessment and diagnosis of patients with acute coronary syndromes and stroke and facilitate the development of new treatments.
The Buchan Group's Laboratory of Cerebral Ischemia is a pre-clinical research group aiming to uncover mechanisms of cell death in stroke, and develop novel strategies to reduce this. Group members have also developed in-vitro models for neurological diseases, and work on neuroimmunology.
The MRC Translational Immune Discovery Unit (TIDU) aims to uncover the molecular pathways driving immune-mediated diseases – researchers in the unit develop and harness new technologies to map the causes and molecular drivers of a series of inflammatory disorders in order to develop better ways to treat them.
Professor Alison Simmons is the Head of Investigative Medicine.